TABLE 2.

Correlations between anthropometric and metabolic parameters with measures of the peripheral endocannabinoid system

	Male				Female
	CB1 receptor visceral mRNA	FAAH visceral mRNA	2-AG	Anandamide	CB1 receptor visceral mRNA	FAAH mRNA	2-AG	Anandamide
Age	0.003	0.08	−0.01	−0.15	−0.43*	−0.45*	0.41*	−0.1
BMI	−0.5†	−0.35	0.55†	0.26	−0.65†	−0.64†	0.64†	0.21
Visceral abdominal adipose tissue area	−0.53†	−0.38*	0.52†	0.31	−0.64†	−0.56†	0.65†	0.23
Percent body fat	−0.49†	−0.19	0.3	0.15	−0.62†	−0.43*	0.5†	0.14
Fasting plasma glucose	−0.003	−0.37*	0.23	0.22	−0.14	0.25	−0.06	0.18
Fasting insulin	−0.4*	−0.4*	0.41*	0.2	−0.58*	−0.3	0.42*	0.15
GIR	0.4	0.58†	−0.5*	−0.2	0.3	0.06	−0.32	−0.11
Free fatty acid	−0.02	−0.04	0.15	0.1	−0.49†	−0.3	0.4*	0.1

GIR, glucose infusion rate during the steady state of an euglycemic-hyperinsulinemic clamp.

^*P < 0.05;

^†P < 0.01.